EN
HI
Summary
As of 10 Nov, 2026, Brooks Laboratories stock price is ₹65.75. During the trading session, the stock has moved between an intraday low of ₹65.25 and an intraday high of ₹68.90. Over the last 52 weeks, Brooks Laboratories has traded between ₹52.97 and ₹75.60.
The stock has recorded a trading volume of 24,798 shares,. Its Average Traded Price (ATP) is ₹66.25, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 172 @ ₹65.75.
Brooks Laboratories has an upper circuit limit of ₹79.15 and a lower circuit limit of ₹52.77. The total value traded stands at ₹16.43 L, and the delivery percentage for the day is 69.86%.
The stock is currently traded with a market lot size of 1. Brooks Laboratories also offers a dividend yield of 0%.
Brooks Laboratories Share Price Chart
Brooks Laboratories Share Key Metrics
Volume
24798.00
Market Cap
193.68 CR
LTQ@LTP
172@65.75
ATP
66.25
Var Margin
30.93 %
Circuit Range
52.77-79.15
Delivery %
69.86 %
Value
16.43 L
ASM/GSM
No
Market Lot
1
Brooks Laboratories Fundamentals
P/E Ratio
14.78
P/B Ratio
1.57
Div. Yield
0
Sector P/E
40.79
Sector P/B
3.79
Sec. Div. Yield
0.53
Brooks Laboratories Resistance and Support
Pivot 65.43
Resistance
First Resistance
66.94
Second Resistance
67.93
Third Resistance
69.44
Support
First Support
64.44
Second Support
62.93
Third Support
61.94
Brooks Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 67.9 | 65.75 | -0.30% | 68.9 | 65.25 |
| Sun Nov 08 2026 | 64.26 | 65.95 | 4.27% | 66.41 | 63.91 |
| Fri Nov 06 2026 | 65.98 | 63.25 | -4.80% | 67.9 | 62.59 |
Brooks Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-07 | Quarterly Results |
| 2026-02-06 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-02-13 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Brooks Laboratories News
Brooks Laboratories Ltd - 533543 - Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended September 30, 2026
Brooks Laboratories reported Q2 FY27 cons. revenue of ₹19.25 crore and a net profit of ₹67.61 crore. The profit surge is attributed to an exceptional gain of ₹74.70 crore from divesting an 11.48% stake in Brooks Steriscience for ₹74.74 crore.
Nov 07 2026 18:06:08
Brooks Laboratories Ltd - 533543 - Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended September 30, 2026
Brooks Laboratories reported Q2 FY27 total income of ₹20.23 crore and a net profit of ₹67.61 crore. The significant profit jump is attributed to an exceptional gain of ₹74.70 crore from the partial divestment of an 11.48% stake in Brooks Steriscience Ltd for ₹74.74 crore. The company retains a 37.52% stake post-transaction.
Nov 07 2026 17:54:26
Read More
Brooks Laboratories Management
| Name | Position |
|---|---|
| Krutika Mohan Rane | Company Secretary & Compliance Officer |
| Bhushan Singh Rana | Whole Time Director |
Brooks Laboratories FAQs
The Buying Price of Brooks Laboratories share is 65.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Brooks Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Brooks Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Brooks Laboratories shares is 14.78. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Brooks Laboratories shares is 1.57. Useful to assess the stock's value relative to its book value.
To assess Brooks Laboratories’s valuation compare Sector P/E, P/B which are 40.79 & 3.79 with sector averages, along with growth rates and financial metrics.
The Market Cap of Brooks Laboratories is 193.68 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Brooks Laboratories share price is 75.60 & 52.97. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Brooks Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BROOKS
